Open R&D

Open R&D: we build the future of Zambon

Il valore dell’impresa aperta nella ricerca

The value of a business open to research

We wish to establish a pipeline of proprietary products with a global presence, relying on the knowledge, talent and skills of all those who work within the company as well as those who work with us from outside the company. At Zambon, this research goal is based on cooperation with a network of research centers across the world. 

Il nostro focus

Our focus

We are moving from having many local projects toward establishing a global pipeline focused on specialties, with the aim of exploring new potential therapeutic indications and developing new proprietary drugs in new fields.

 Guardiamo al futuro

Looking to the future

We continue to look to the future by exploring new ways of conducting R&D, using Big Data and new technologies based on machine learning.

Our pipeline

Our ongoing clinical trials

PIPELINE - Respiratory

Preclinical
Phase 1
Phase 2
Phase 3
Phase 4
Phase 3
US: CMS & I-Neb for Non-Cystic Fibrosis Bronchiectasis (NCFB)
Phase 3
EU: CMS & I-Neb for Non-Cystic Fibrosis Bronchiectasis (NCFB)
Phase 2
Phase 3
US: CMS & I-Neb Cystic Fibrosis (CF)

PIPELINE - Anti-infectives

Preclinical
Phase 1
Phase 2
Phase 3
Phase 4
Preclinical
Novel antibiotic
Preclinical
Inhaled product for pulmonary fungal infection

PIPELINE - CNS: Parkinson's Disease

Preclinical
Phase 1
Phase 2
Phase 3
Phase 4
Phase 3
Safinamide for levodopa-induced dyskinesia
Phase 4
Safinamide for Pain in PD patients
Phase 2
Safinamide for MSA